Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc > Nice big cup and handle formed ready to break out

<< Previous

Bullboard Posts

Next >>

Comment by FriedChickenon Feb 07, 2021 4:43pm

119 Views

Post# 32496792

RE:RE:RE:RE:RE:RE:RE:RE:RE:Nice big cup and handle formed ready to break out

Goody, I'm so happy that you're impressed with all the hard work I put into that.

Market cap, sp, ratios, oh my. 1000 words. Quite the assignment. I'll really really try harder this time, OK? Do I also get extra credit if put it all in a binder, and draw a pretty mushroom on the cover?

See you at $2.00 my lord.

Cheers,
FC

<< Previous

Bullboard Posts

Next >>

Debt-free cannabis company set for next stage of growth